Kidney Care Coordination Across Settings

Abstract

Effective coordination of kidney care across healthcare settings is paramount to improving outcomes for patients with chronic kidney disease (CKD) and those at risk of acute kidney injury (AKI). This article reviews the epidemiological landscape, pathophysiological mechanisms, risk factors, clinical presentations, diagnostic approaches, and treatment strategies in kidney care. Emphasis is placed on the challenges and solutions in integrating care across outpatient, inpatient, and transitional settings, supported by recent advances and updated guideline recommendations. The review aims to provide clinicians and healthcare professionals with a comprehensive, evidence-based synthesis to inform practice and optimize multidisciplinary kidney care delivery.

Introduction

Chronic kidney disease and acute kidney injury represent major global health burdens, with substantial morbidity, mortality, and economic impact. The complexity of kidney care is amplified by the necessity for seamless transitions between primary care, specialty nephrology, hospital settings, and dialysis or transplant centers. Fragmentation of care contributes to preventable complications, delayed interventions, and suboptimal patient outcomes. Recent shifts in healthcare models emphasize the necessity for coordinated, patient-centered care leveraging multidisciplinary teams, health information exchange, and evidence-based protocols.

Epidemiology / Disease Burden

CKD affects an estimated 10-15% of the global population, with higher prevalence in aging populations and those with diabetes or hypertension. AKI complicates up to 20% of hospital admissions, significantly increasing risk of progression to CKD and end-stage kidney disease (ESKD). Hospital readmissions following AKI or advanced CKD are common, highlighting deficiencies in post-discharge care coordination. The economic burden is substantial, with costs driven by hospitalizations, dialysis, and comorbidities. Population-level data support that improved care coordination can reduce morbidity, mortality, and healthcare expenditures.

Pathophysiology

CKD is characterized by progressive nephron loss, glomerulosclerosis, tubulointerstitial fibrosis, and maladaptive responses to injury. Factors such as persistent hyperglycemia, hypertension, and chronic inflammation drive disease progression through mechanisms including oxidative stress, endothelial dysfunction, and activation of the renin-angiotensin-aldosterone system (RAAS). AKI involves abrupt loss of kidney function due to ischemic, toxic, or inflammatory insults, often superimposed on CKD. Pathophysiological overlap between AKI and CKD underscores the need for vigilance and proactive management across care settings.

Risk Factors

Major risk factors for CKD include advanced age, diabetes mellitus, hypertension, cardiovascular disease, obesity, family history of kidney disease, and exposure to nephrotoxic agents. AKI risk factors are multifactorial, encompassing volume depletion, sepsis, nephrotoxic medications, contrast agents, and preexisting CKD. Social determinants of health, including reduced access to care and socioeconomic disparities, contribute to poor outcomes and must be addressed in coordinated care strategies.

Clinical Features

Early CKD is often asymptomatic, detected through laboratory abnormalities such as reduced estimated glomerular filtration rate (eGFR) and proteinuria. As disease advances, patients may develop hypertension, anemia, electrolyte disturbances, mineral bone disease, and uremic symptoms. AKI is characterized by abrupt decreases in urine output, rising serum creatinine, and fluid-electrolyte imbalances. Clinical presentation varies by etiology and comorbidities, necessitating individualized assessment and monitoring across settings.

Diagnosis

Diagnosis of kidney dysfunction is based on serial measurement of eGFR, urinalysis for proteinuria/hematuria, and imaging studies such as renal ultrasound. Biomarkers (e.g., NGAL, KIM-1) are under investigation for early detection of AKI. Risk stratification tools and electronic health record (EHR) algorithms facilitate early identification of at-risk patients. Timely diagnosis is essential for prompt intervention and minimizing long-term sequelae, emphasizing the need for coordinated communication between providers.

Treatment & Management

Management of CKD focuses on blood pressure and glycemic control, RAAS inhibition, lipid management, dietary modification, and avoidance of nephrotoxins. Multidisciplinary teams including nephrologists, primary care, dietitians, pharmacists, and social workers are integral to comprehensive care. AKI management is supportive, centered on hemodynamic optimization, volume status, and minimizing further nephrotoxic exposure. Transitional care models and dedicated kidney care coordinators have demonstrated benefit in reducing hospital readmissions, optimizing medication reconciliation, and ensuring guideline-concordant follow-up.

Recent Advances / Emerging Therapies

SGLT2 inhibitors have emerged as a transformative therapy in CKD, providing cardiovascular and renal protection beyond glycemic control. Non-steroidal mineralocorticoid receptor antagonists and novel anti-fibrotic agents are under active investigation. Digital health interventions, including remote monitoring, telemedicine, and EHR-integrated care pathways, are improving care transitions and enabling real-time risk stratification. Artificial intelligence tools for early AKI prediction and care navigation are being piloted in academic centers, with promising results for scalability and impact.

Guideline Recommendations

Recent KDIGO and NICE guidelines emphasize risk-based screening, early referral to nephrology, and structured care pathways for CKD and AKI. Recommendations include routine assessment of kidney function in high-risk populations, individualized blood pressure and glycemic targets, and integration of patient education. Coordination between primary and specialty care, medication reconciliation at transitions, and post-discharge follow-up are strongly endorsed as quality measures. Shared decision-making and patient engagement are critical components of effective kidney care coordination.

Conclusion

Optimizing kidney care coordination across healthcare settings is essential for improving outcomes in CKD and AKI. Multidisciplinary collaboration, evidence-based management, and seamless communication are cornerstones of effective care. Recent advances in therapeutics, digital health, and risk stratification support an evolving paradigm focused on proactive, patient-centered management. Continued integration of guideline-driven protocols and innovative care models will be pivotal in addressing the growing burden of kidney disease and enhancing quality of care for this vulnerable population.